Glutathione is not effectively transported into human lymphoid cells, normal human skin fibroblasts, and fibroblasts from patients with genetic deficiencies of yglutamylcysteine synthetase or glutathione synthetase. On the other hand, the monoethyl ester of glutathione, in which the carboxyl group of the glycine residue is esterified, is readily transported into these cells and is hydrolyzed intracellularly. This leads to greatly increased cellular levels of glutathione, which often exceed those found normally. Glutathione ester was found to protect human lymphoid cells of the CEM line against the lethal effects of irradiation. Under the conditions employed, complete protection was found when the ester was added prior to irradiation. Addition of the ester after irradiation was partially effective, suggesting that GSH may also function in repair processes.
employed, complete protection was found when the ester was added prior to irradiation. Addition of the ester after irradiation was partially effective, suggesting that GSH may also function in repair processes.
There is currently much interest in procedures that increase cellular levels of glutathione (GSH) because of growing evidence that GSH plays an important role in the protection of cells against damage by radiation and by reactive oxygen compounds and other toxic substances (1, 2) . Cellular levels of GSH may be raised to some extent by increasing the supply of the amino acids required for GSH synthesis, especially cysteine, which is a substrate for the first step in GSH biosynthesis catalyzed by y-glutamylcysteine synthetase. L-2-Oxothiazolidine-4-carboxylate, which is readily transported and converted to L-cysteine intracellularly by 5-oxoprolinase, promotes GSH synthesis (3, 4) . Administration of yglutamylcysteine, a substrate of GSH synthetase, which catalyzes the second step, may increase cellular GSH levels to values higher than the feedback-regulated levels (5) . Administered GSH does not seem to enter most cells to an appreciable extent; in contrast, there is considerable evidence that many cells export GSH (6) .
An ideal cellular delivery system for GSH might be based on a derivative of GSH that is (i) much more effectively transported into cells than is GSH itself and (ii) is readily converted to GSH after transport. Observations made previQusly in this laboratory showed that administration of the monoethyl (or methyl) ester of GSH to mice leads to substantial increases in the GSH levels of the liver and kidney, and the findings indicated that these compounds are transported and then hydrolyzed intracellularly (7) . The use of esters of GSH is attractive because (i) many cells appear to have high levels of esterase capable of effectively converting such compounds to GSH; (ii) the formation of intracellular GSH from this type of derivative does not require intracellular energy as is required for de novo GSH synthesis; and (iii) since the delivery of GSH by means of its ester does not involve GSH synthesis, the levels of cellular GSH achieved would not be subject to feedback inhibition by GSH (8) .
In the present work, we have examined the potential usefulness of the monoethyl ester of GSH as a cellular GSH delivery system in studies on several human lymphoid cell lines. The GSH ester was found to protect lymphoid cells against the effects of radiation. We have also examined normal human skin fibroblasts and fibroblasts obtained from patients with genetic deficiencies of glutathione synthetase and of y-glutamylcysteine synthetase. The results indicate that GSH ester is very effectively transported into these cells and that high cellular levels of GSH can readily be achieved; indeed, the GSH levels are often much higher than normally found. Suspension of cells in medium containing GSH may be followed by extracellular breakdown of GSH, transport of the products,' and intracellular synthesis of GSH (9) . To inhibit this pathway, we pretreated the cells used in some experiments with buthionine sulfoximine, an irreversible inhibitor of y-glutamylcysteine synthetase (10) (11) (12) (13) (14) .
EXPERIMENTAL PROCEDURES
Materials. Human lymphoid cell lines CEM, HSB, and MOLT and skin fibroblast cultures from patients with 5-oxoprolinuria (15, 16) (GSH synthetase deficiency; GM 3878 and GM 3877) were obtained from the Institute for Medical Research, Human Cell Repository (Camden, NJ). The normal fibroblast line (CRL-1530) was obtained from the American Type Culture Collection. Cultures of skin fibroblasts from patients with y-glutamylcysteine synthetase deficiency (17, 18) were supplied by J. Schneider (University of California, San Diego).
RPMI 1640 medium (with glutamine) (medium A) and RPMI 1640 medium (with glutamine) lacking cysteine and GSH (medium B), minimal essential medium containing Earle's salts and glutamine, MEM (with Earle's salts and glutamine, not containing GSH and cysteine), Dulbecco's phosphate-buffered saline lacking Ca2" and Mg2+, Hanks' balanced salt solution lacking Ca2`and Mg2+, heat-inactivated fetal calf serum, penicillin, streptomycin, trypan blue, and trypsin were obtained from GIBCO. Glutathione disulfide (GSSG) reductase, NADPH, and GSH were obtained from Sigma. L-Buthionine-SR-sulfoximine (10-12) and GSH monoethyl ester (y-glutamylcysteinylglycyl ethyl ester) (7) were obtained as described.
Methods. The lymphoid cell lines were grown in an atmosphere of 5% CO2/95% air in RPMI 1640 medium containing 17%o heat-inactivated fetal calf serum and 100 units each of streptomycin and penicillin per 500 ml. The cells (106 per ml) were used 24 hr after adcing fresh medium. The cell number and viability (by trypan blue exclusion) were determined at the end of the experiments; cell viability was 90-100% at this time. For GSH determinations, 3-4 x 106 cells were collected by centrifugation and washed twice with phosphate-buffered saline, and the cell pellet was suspended in 0.15 ml of 0.1 M HCl and frozen. The cells were broken by freezing and Abbreviations: GSH, glutathione; GSSG, glutathione disulfide.
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thawing three times and the protein was then precipitated by adding 10% sulfosalicylic acid to a final concentration of 3.3%. After centrifugation (Beckman Microfuge), GSH analyses were performed by the GSSG reductase/dithionitrobenzoic acid recycling method (19, 20) .
The fibroblasts were grown in minimal essential medium containing Earle's salts, glutamine, and 10% heat-inactivated fetal calf serum and antibiotics and were used when the cells became confluent. At the end of the experiments, trypsin was added at 250C and, after 3-5 min, the cells were lifted from the flask surface and suspended in Hanks' solution. The cells were collected by centrifugation, washed twice with Hanks' solution, and counted. The packed cells (0.3-1 x 106) were suspended in 0.15 ml of 0.1 M HCl and analyzed for GSH as described above.
Cells were irradiated with a 60Co source (Gammacell 200;  Atomic Energy of Canada, Ltd.). After irradiation, viability was monitored by trypan blue dye exclusion.
RESULTS
In the experiments described in Fig. 1 , human lymphoid cells of the HSB, MOLT, and CEM lines were depleted of GSH by incubation for 24 hr in medium containing buthionine sulfoximine; the cells were then suspended in medium containing GSH ester (Fig. 1, curves 3) . Within 4 hr, the intracellular levels of GSH increased substantially in each of the cell types studied, whereas there was no significant change in cellular GSH levels in untreated controls (curves 1) or in cells that were placed in medium containing an equivalent concentration of GSH (curves 2). Incubation of the cells for longer than 4 hr led to additional increases in cellular GSH, to values that were significantly higher-i.e., 2-3 nmol per 106 cells-than those found in these cell lines when grown under the usual conditions. In studies in which the concentration of GSH ester in the medium was 10 mM, the intracellular level increased to about 4 nmol per 106 cells. The usual range of cellular GSH levels found when these cells are grown under standard conditions is 0.8-1.9 nmol per 106 cells (or 0.8-1.9 mM).
The effect of varying the concentration of GSH ester in the medium over the range 1 to 5 mM on cellular GSH levels was determined by incubating the cells under similar conditions to those used in the studies described in Fig. 1 . The cellular GSH levels achieved after 2 hr were directly related to the level of GSH ester in the medium (Fig. 2) The experiments described in Fig. 3 show that GSH ester protects CEM cells against the effects of irradiation. The number of viable cells decreased steadily in the controls over a period of 120 hr (curve 1). When the cells were suspended in medium containing GSH ester before irradiation (curve 3), the number of viable cells increased substantially, and indeed the number of cells increased at a rate about the same as that found for untreated cells of this cell line. Partial protection was found when the cells were suspended in medium containing GSH prior to irradiation (curve 4) and when GSH ester was added after irradiation (curve 2).
The experiments summarized in Table 1 indicate that GSH ester is also effectively transported into cultured human skin fibroblasts. These studies were carried out with normal fibroblasts, with fibroblasts obtained from two patients with a marked deficiency of glutathione synthetase, and with fibroblasts from two patients with a marked deficiency of y-glutamylcysteine synthetase. The level of GSH usually found in normal fibroblasts is rarely higher than about 2 nmol per 106 cells and is generally in the range 0.8 to 1.5 nmol per 106 cells. After incubation with GSH ester, values of cellular GSH that were substantially higher than this were found in normal fibroblasts (Table 1 , experiments 1 and 2). GSH ester was also very effectively transported into fibroblasts from patients with both types of GSH synthesis deficiency (Table  1 , experiments [3] [4] [5] [6] [7] [8] [9] . Suspension of the fibroblasts in medium containing GSH led to much smaller increases in cellular GSH levels than those found with GSH ester. Although it would be expected that GSH ethyl ester would be readily susceptible to oxidation and to hydrolysis in tissue culture media and in vivo, the present and previous (7) results indicate that GSH ethyl ester has sufficient stability in vitro and in vivo to serve as a substantial substrate for transport. Analysis of the suspending medium during the course of these experiments shows that appreciable oxidation of GSH monoethyl ester occurs as well as some cleavage of the ester group. Because both oxidation and hydrolysis of the ester occur, together with some formation of GSSG, it has thus far been difficult to quantitate each type of breakdown of GSH ester in the medium. Such breakdown is markedly affected by various components of the culture medium (e.g., metal ions, serum proteins) and also by pH. In this connection, it is important to maintain the pH of solutions of the ester at values less than 7.6; even brief periods at higher pH values may lead to rapid hydrolysis.
A number of studies have indicated that the transport of GSH monoethyl ester is not significantly affected by the simultaneous presence of relatively high concentrations of GSH. This is consistent with previous findings that GSH is not appreciably transported (9, 13) and with the interpretation that GSH ester is much more readily accepted into the cell membrane. Transport of the ester seems to be proportional to concentration of the ester in the medium over a wide range; this process probably occurs by diffusion. Further studies on the properties of this transport phenomenon are needed.
The protection of lymphoid cells observed in the presence of GSH ester is in accord with earlier findings (9) , which showed that protection requires intracellular GSH. That partial protection was found in cells that were incubated with GSH prior to irradiation probably reflects some uptake of GSH degradation products and intracellular GSH synthesis, as previously observed (9) . That partial protection was found when GSH ester was added after irradiation suggests that some cellular damage is reversible and that GSH may function in repair processes as well as in protection.
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